Some leaders build successful businesses. Others build institutions that inspire change. In our latest cover story, Business Leader Magazine is proud to feature Dr. Lovekush Singh, a researcher, entrepreneur, and healthcare innovator whose journey reflects a unique blend of scientific inquiry, Ayurvedic wisdom, and visionary leadership. From his academic pursuits and research contributions to founding Anupam Group India and leading AYUGENIX Bioscience Limited, Dr. Singh has dedicated his career to advancing evidence-based healthcare while fostering innovation across multiple industries. His story is one of perseverance, purpose, and the belief that sustainable success is achieved by creating value for society. We are delighted to present this exclusive feature, offering our readers an inspiring insight into the vision, philosophy, and entrepreneurial journey of a leader committed to shaping the future of healthcare and business. We thank Dr. Lovekush Singh for sharing his remarkable journey with our readers and invite you to explore this special edition of Business Leader Magazine. — Archana Raghvendra Mishra Editor, Business Leader Magazine
Recognizing the increasing role of digital transformation in modern business, the group later diversified into Information Technology through Anupam Infotech, reflecting Dr. Singh's belief that technology should support organizational efficiency, healthcare accessibility, and business innovation.
The journey of diversification continued with the establishment of operations in the Textile segment, represented by GLOWERZ, which later evolved into KashiVastram PariDhanm. This expansion demonstrated that the entrepreneurial philosophy of Anupam Group India extended beyond healthcare, embracing sectors where quality, innovation, and customer satisfaction remained equally important.
Together, these subsidiaries transformed Anupam Group India into a multidimensional business group operating across healthcare, pharmaceuticals, business services, information technology, and textiles.
Entrepreneurship in the Midst of a Global Crisis
No entrepreneurial journey is free from adversity, and one of the greatest challenges faced by Anupam Group India emerged unexpectedly.
Within the first few years of expansion, the world was confronted by the COVID-19 pandemic-a crisis that disrupted economies, healthcare systems, supply chains, and businesses across every industry.
For Anupam Group India, the impact was severe. The organization experienced an estimated 50 percent reduction in its overall business, placing enormous pressure on financial resources, operations, and future planning.
For many emerging enterprises, such a setback could have marked the end of their journey. Instead, Dr. Lovekush Singh viewed the crisis as a test of leadership and resilience. Rather than abandoning long-term objectives, the organization adapted its strategies, reassessed priorities, and continued investing in innovation. The healthcare background of its leadership also provided valuable insight into the rapidly changing needs of society during the pandemic. This period reinforced the importance of flexibility, disciplined management, and maintaining confidence even under extraordinary circumstances.
The experience ultimately strengthened the organization's culture, demonstrating that resilience is often built through adversity rather than success alone.
As global conditions gradually stabilized, Anupam Group India entered a new phase of growth characterized by strategic expansion and organizational restructuring.
Between 2019 and 2026, the group broadened its business activities through the establishment of new ventures, the acquisition of complementary businesses, and the integration of multiple operations under stronger organizational frameworks.
A significant milestone during this period was the continued development of Anupam Pharmaceutical Pvt. Ltd., providing greater focus to pharmaceutical operations while supporting research-driven product development.
At the same time, AYUGENIX Bioscience Ltd. was reformed and strengthened as the group's flagship healthcare and bioscience organization. This transformation reflected Dr. Singh's long-term commitment to integrating scientific research, Ayurvedic medicine, pharmaceutical innovation, and holistic healthcare into a unified institutional framework.